Trials / Unknown
UnknownNCT03924258
Study of the Prevalence of Iron Deficiency in Patients With Heart Failure
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,300 (estimated)
- Sponsor
- VIFORFRANCE · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Despite its known prevalence in Heart Failure, a recent study conducted by Prof. Cacoub (unpublished) on the French national health insurance database showed that iron deficiency was a poorly diagnosed and poorly treated comorbidity. In chronic diseases including Heart Failure, Transferrin Saturation Factor is only performed in about 10% of cases while it is recommended for patients with Heart Failure (French Health High Authority 2011). The purpose of this study is to obtain current data on the prevalence of iron deficiency in France in patients with Heart Failure, applying the recommendations of European Society of Cardiology and French Health High Authority (determination of ferritinemia and Transferrin Saturation Factor).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Iron status testing | Blood sample for iron status testing |
Timeline
- Start date
- 2019-05-15
- Primary completion
- 2019-06-30
- Completion
- 2019-06-30
- First posted
- 2019-04-23
- Last updated
- 2019-04-23
Source: ClinicalTrials.gov record NCT03924258. Inclusion in this directory is not an endorsement.